SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-17-009142
Filing Date
2017-02-24
Accepted
2017-02-24 16:25:41
Documents
4
Period of Report
2017-04-11
Effectiveness Date
2017-02-24

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS INC. DEF 14A 4-11-2017 formdef14a.htm DEF 14A 660097
2 image1.jpg GRAPHIC 257267
3 image00002.jpg GRAPHIC 55686
4 logo.jpg GRAPHIC 2663
  Complete submission text file 0001140361-17-009142.txt   1096240
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34079 | Film No.: 17637715
SIC: 2834 Pharmaceutical Preparations